InClinica
Wayne, Pennsylvania, United States
About InClinica
InClinica is a global clinical contract research organization founded in 2016 after the acquisition of an existing global CRO. With a senior management team that brings more than 100 combined years of experience, InClinica works across all phases of the clinical research process and has a particular strength in first in man and phase 2 studies. InClinica is headquartered in Philadelphia with other locations in the U.K., Israel, and Malaysia/Singapore. InClinica is a global clinical CRO that specializes in leading companies through clinical trials. The company was founded in 2016 through the acquisition of an existing global clinical CRO. Our senior management team has more than a century of internal drug development experience. We have experience in multiple diseases and device technologies, conducted across all stages of clinical trials, in North America, Asia/Pacific, Europe and Latin America.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $4.4M
- Funding stage: M&A
- Last round: Series Unknown (Mar 2012)
- Website: inclinica.com
- Phone: (610)230-2444
Industries & Categories
Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/inclinica-2486399 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.